The global market for treating Dry Eye Syndrome reached a value of USD 4.29 Billion in 2022 and is anticipated to reach USD 6.21 Billion by 2032, with a swift revenue Compound Annual Growth Rate (CAGR) of 4.2% throughout the forecast period. Key drivers for the market’s revenue growth include the increasing elderly population, advancements […]
